CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin\, 20%\, subcutaneous]\, at the 2019 Peripheral Nerve Society Annual Meeting